Matej Mikulic
Research expert covering health, pharma & medtech
Biotech SMEs – statistics & facts
Throughout the COVID-19 pandemic, small and medium-sized enterprises (SMEs) and emerging therapeutic companies (ETCs) have had the spotlight turned on them. Two biotech companies, in particular, attracted great attention: Germany-based BioNTech and U.S.-based Moderna. These two were the first to develop and market safe and effective COVID-19 vaccines available to large parts of the world’s population. Typically, both companies have not been profitable yet, but their big financial breakthrough is expected to come in 2021. However, the rising market value of the companies – visible in their share prices – is already a fact. Currently, Moderna is listed as one of the leading biopharma companies worldwide based on market capitalization.
